Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.
about
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.Progressive changes in inflammatory and matrix adherence of bronchial epithelial cells with persistent respiratory syncytial virus (RSV) infection (progressive changes in RSV infection).A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.Advances in and the potential of vaccines for respiratory syncytial virus.Recent advances in the development of subunit-based RSV vaccines.Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice.Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma.
P2860
Q34542687-7C526036-A736-4853-B0FD-BF96A213BB00Q37032264-57669FAB-DCC5-4A40-9026-A608213790A0Q37225085-4DBED0D9-8E0D-43C8-9327-3F02B11AFBC6Q37547653-B1C2F538-54B6-452C-B395-45668812D9B7Q38130514-967FDE11-F0A0-418E-9905-2E1A979C46F4Q38617302-9BF0897D-8669-4370-BD29-3D105A57D525Q40866223-86852773-0A6B-47B6-A763-9E76908D87E6Q55293109-C435EEB0-936C-45B9-B90A-4AF78FD3702B
P2860
Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Nucleoprotein nanostructures c ...... candidate mucosal RSV vaccine.
@ast
Nucleoprotein nanostructures c ...... candidate mucosal RSV vaccine.
@en
Nucleoprotein nanostructures c ...... candidate mucosal RSV vaccine.
@nl
type
label
Nucleoprotein nanostructures c ...... candidate mucosal RSV vaccine.
@ast
Nucleoprotein nanostructures c ...... candidate mucosal RSV vaccine.
@en
Nucleoprotein nanostructures c ...... candidate mucosal RSV vaccine.
@nl
prefLabel
Nucleoprotein nanostructures c ...... candidate mucosal RSV vaccine.
@ast
Nucleoprotein nanostructures c ...... candidate mucosal RSV vaccine.
@en
Nucleoprotein nanostructures c ...... candidate mucosal RSV vaccine.
@nl
P2093
P2860
P1433
P1476
Nucleoprotein nanostructures c ...... candidate mucosal RSV vaccine
@en
P2093
Agnès Petit-Camurdan
Aude Remot
Catherine Dubuquoy
Mohammed Moudjou
Sabine Riffault
Stephan Bouet
Xavier Roux
P2860
P304
P356
10.1371/JOURNAL.PONE.0037722
P407
P577
2012-05-24T00:00:00Z